A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.

Completed · Phase 4

Conditions studied: Influenza

In brief

This study will evaluate the safety of Tamiflu, when used for the prevention of influenza in children during the flu season. Children who would benefit from influenza prophylaxis when influenza is circulating in the community will receive treatment with Tamiflu syrup (or capsules) 30mg-75mg once daily (dependent on body weight) for 6 weeks. Safety data and influenza symptoms will be recorded throughout the study. The anticipated time on study treatment is \<3 months, and the target sample size is \<100 individuals.

Key facts

Study ID

NCT00412555

Run by

Hoffmann-La Roche

People needed

52

Starts

2006-12-01

Expected to finish

2007-05-01

Last updated by the study team

2020-08-18

Who can join

Age: 1 and older, up to 12. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• males or females, 1-12 years of age;
• candidate for seasonal prophylaxis;
• negative rapid diagnostic test for influenza at baseline.

You may not qualify if…

• symptoms suggestive of influenza-like illness;
• positive rapid diagnostic test for influenza;
• antiviral treatment for influenza in 2 weeks prior to randomization.

Where it is running

• Study site — West Palm Beach, Florida, United States
• Study site — Pittsburgh, Pennsylvania, United States
• Study site — Jackson, Tennessee, United States
• Study site — El Paso, Texas, United States
• Study site — Coquitlam, British Columbia, Canada
• Study site — Aalborg, Denmark

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.